Fig. 2.
Fig. 2. Summary of huCD45+ cell subpopulations found in mouse BM (A), spleen (B), and PB (C). The percent of the huCD45+ population that also expressed human myeloid cell (CD13/33+ and CD14+), B cell (CD19+), erythroid progenitor cell (gA+71+45−), and CD34+ cell surface markers is shown for all samples analyzed from experiments 1 through 8. Median values are shown above each subpopulation. Samples are identified from experiments 1 (▴, ▵) and 2 (▪, □) where mice received either 10 μg each of human: IL-3, SCF, and GM-CSF, three times per week (▴, ▪), or received no growth factor treatments (▵, □).

Summary of huCD45+ cell subpopulations found in mouse BM (A), spleen (B), and PB (C). The percent of the huCD45+ population that also expressed human myeloid cell (CD13/33+ and CD14+), B cell (CD19+), erythroid progenitor cell (gA+71+45), and CD34+ cell surface markers is shown for all samples analyzed from experiments 1 through 8. Median values are shown above each subpopulation. Samples are identified from experiments 1 (▴, ▵) and 2 (▪, □) where mice received either 10 μg each of human: IL-3, SCF, and GM-CSF, three times per week (▴, ▪), or received no growth factor treatments (▵, □).

Close Modal

or Create an Account

Close Modal
Close Modal